CONCIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 05:11:27 GMT 2023` Edited by `admin` on `Sat Dec 16 05:11:27 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	68603V9EAF
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CONCIZUMAB

Official Name

English

NN7415

Code

English

CONCIZUMAB [USAN]

Common Name

English

Concizumab [WHO-DD]

Common Name

English

NN-7415

Code

English

NNC01722021

Code

English

MAB-2021

Code

English

NNC0172-2021

Code

English

CONCIZUMAB [JAN]

Common Name

English

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TFPI (TISSUE FACTOR PATHWAY INHIBITOR, LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR)), HUMANIZED MONOCLONAL ANTIBODY

Common Name

English

NNC172-2021

Code

English

MAB2021

Code

English

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TISSUE FACTOR PATHWAY INHIBITOR (LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR, TFPI))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-448) (HUMANIZED VH (HOMO SAPIENS IGHV3-21*01 (86%) (IGHD)-IGHJ6*01 (93%)

Common Name

English

concizumab [INN]

Common Name

English

NNC-0172-0000-2021

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

653618

Created by admin on Sat Dec 16 05:11:27 GMT 2023 , Edited by admin on Sat Dec 16 05:11:27 GMT 2023

FDA ORPHAN DRUG

663618

Created by admin on Sat Dec 16 05:11:27 GMT 2023 , Edited by admin on Sat Dec 16 05:11:27 GMT 2023

EU-Orphan Drug

EU/3/17/1940

Created by admin on Sat Dec 16 05:11:27 GMT 2023 , Edited by admin on Sat Dec 16 05:11:27 GMT 2023

Code System Code Type Description

USAN

HI-127

Created by admin on Sat Dec 16 05:11:27 GMT 2023 , Edited by admin on Sat Dec 16 05:11:27 GMT 2023

PRIMARY

INN

9636

Created by admin on Sat Dec 16 05:11:27 GMT 2023 , Edited by admin on Sat Dec 16 05:11:27 GMT 2023

PRIMARY

DRUG BANK

DB12820

Created by admin on Sat Dec 16 05:11:27 GMT 2023 , Edited by admin on Sat Dec 16 05:11:27 GMT 2023

PRIMARY

NCI_THESAURUS

C166914

Created by admin on Sat Dec 16 05:11:27 GMT 2023 , Edited by admin on Sat Dec 16 05:11:27 GMT 2023

PRIMARY

CAS

1312299-39-0

Created by admin on Sat Dec 16 05:11:27 GMT 2023 , Edited by admin on Sat Dec 16 05:11:27 GMT 2023

PRIMARY

FDA UNII

68603V9EAF

Created by admin on Sat Dec 16 05:11:27 GMT 2023 , Edited by admin on Sat Dec 16 05:11:27 GMT 2023

PRIMARY

From	To
1_22	1_96
1_148	1_204
1_262	1_322
1_368	1_426
2_22	2_96
2_148	2_204
2_262	2_322
2_368	2_426
3_23	3_93
3_139	3_199
4_23	4_93
4_139	4_199
1_135	3_219
2_135	4_219
1_227	2_227
1_230	2_230

Glycosylation Link Type	Site
N	1_298
N	2_298

Related Record Type Details


					E1U4X64NFM

TISSUE FACTOR PATHWAY INHIBITOR

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					68603V9EAF

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL